Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
Jeffes EW, Zhang JG, Hoa N, Petkar A, Delgado C, Chong S, Obenaus A, Sanchez R, Khalaghizadeh S, Khomenko T, Knight BA, Alipanah R, Nguyen TV, Shah C, Vohra S, Zhuang JL, Liu J, Wepsic HT, Jadus MR.
Jeffes EW, et al. Among authors: wepsic ht.
J Immunol. 2005 Mar 1;174(5):2533-43. doi: 10.4049/jimmunol.174.5.2533.
J Immunol. 2005.
PMID: 15728459